How well do you understand emerging therapies in multifocal motor neuropathy (MMN)? This Booster Quiz takes you through the pathophysiology of MMN, including the role of the complement pathway in driving disease activity and the disease-targeting mechanism of C2 inhibitor therapies. Explore the evidence behind these emerging agents, review the latest clinical trial data on safety and efficacy, and see how your knowledge aligns with evolving information. In this quiz, you will: Take a closer look at the rationale for C2 complement inhibition in blocking MMN disease activity Examine current clinical trial evidence on the safety and efficacy of emerging therapies for MMN. This activity provides continuing education credits for physicians, physician assistants, nurse practitioners, pharmacists, and nurses through various accrediting agencies in the United States. International learners are encouraged to consult with their local boards and/or agencies for equivalency status.The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found here.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedJan 29, 2026
-
Last day to claim creditJan 29, 2027 4 months left
-
PRIME Education, Inc. (PRIME®) Decoding Multifocal Motor Neuropathy: A Practical Guide to Diagnosis, Pathogenesis, and Emerging Innovations in Treatment
-
PRIME Education, Inc. (PRIME®) Multifocal Motor Neuropathy (MMN) Foundations: Differential Diagnosis in MMN Clinical Practice
-
PRIME Education, Inc. (PRIME®) Multifocal Motor Neuropathy (MMN) Fitted Solutions: Individualized Management, Disease Monitoring, Prognostic Indicators, and Measuring Quality of Life
-
Answers in CME Inc. (AiCME) Complement Is Key: Exploring the Role of C5-Targeted Therapies in Generalized Myasthenia Gravis
-
Consortium of Multiple Sclerosis Centers Escalation of Disease-Modifying Therapy in a Young Woman With Highly Active Relapsing Multiple Sclerosis
-
The Guthy-Jackson Charitable Foundation (GJCF) +1 Emerging Principles & Practices for Imaging
